Related references
Note: Only part of the references are listed.JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Ben Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
How macrophages ring the inflammation alarm
Marco E. Bianchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection
Wei Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
Mariana S. Nars et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
HMGB1 and leukocyte migration during trauma and sterile inflammation
Emilie Venereau et al.
MOLECULAR IMMUNOLOGY (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation
Jian Yang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Novel role of PKR in inflammasome activation and HMGB1 release
Ben Lu et al.
NATURE (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle
Michela Vezzoli et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma
Giuseppe Sconocchia et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization
Neta Erez et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Evaluation of the Role of Tumor-Associated Macrophages in an Experimental Model of Peritoneal Carcinomatosis Using 18F-FDG PET
Lucia Cottone et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
L. Liu et al.
LEUKEMIA (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors
Heikki Rauvala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Endogenous HMGB1 regulates autophagy
Daolin Tang et al.
JOURNAL OF CELL BIOLOGY (2010)
Inhibitor of NK-κB Kinases α and β Are Both Essential for High Mobility Group Box 1-Mediated Chemotaxis
Marianna Penzo et al.
JOURNAL OF IMMUNOLOGY (2010)
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
D. Tang et al.
ONCOGENE (2010)
Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease
Monica Bacci et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1-and MMP-9-dependent pathways
Karine Lolmede et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells
Lara Campana et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Dangers In and Out
Marco E. Bianchi et al.
SCIENCE (2009)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice
Toni M. Robinson-Smith et al.
CANCER RESEARCH (2007)
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin
Valeria V. Orlova et al.
EMBO JOURNAL (2007)
High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells
Emmanouil Chavakis et al.
CIRCULATION RESEARCH (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness - Functional inactivation of rage in L6 myoblasts results in tumor formation in vivo
F Riuzzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
B Degryse et al.
JOURNAL OF CELL BIOLOGY (2001)
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
U Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
